BackContineum Therapeutics Overview

Contineum Therapeutics Accounts Payable

Track Contineum Therapeutics's accounts payable ($510K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$505000.00
↓ 74.76% YoYΔ $-1.50M vs prior year quarter

Peer average

Loading

Contineum Therapeutics Accounts Payable History

Loading

Contineum Therapeutics vs. peers: Accounts Payable Comparison

Loading

Contineum Therapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Contineum Therapeutics (CTNM) FAQ

As of the most recent data (June 2026), CTNM shows a accounts payable of $510K. That compares with $2M in the prior-year period — down 74.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTNM's accounts payable is now $510K (was $2M) — a 74.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Contineum Therapeutics is outperforming or lagging.

Tracking CTNM's accounts payable over time shows whether Contineum Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $510K That compares with $2M in the prior-year period — down 74.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Contineum Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $510K) with ownership activity and broader fundamentals.